ArticleInvestigational new drugs2013

Phase I study of UCN-01 and perifosine in patients with relapsed and refractory acute leukemias and high-risk myelodysplastic syndrome.

Ivana Gojo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.